Study of Irinotecan Plus Capecitabine to Treat Advanced Colorectal Cancer
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to evaluate the efficacy and tolerability of single-week
regimen of irinotecan plus capecitabine in the first-line or second-line treatment of
advanced colorectal cancer.